Molecular pathology, classification, and diagnosis of sporadic human prion disease variants

Folia Neuropathologica

Volumn 50, Issue 1, 2012, Pages 20-45

  Parchi, Piero ^a   Saverioni, Daniela ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

CJD; FFI; Neurodegenerative dementia; Phenotype; Polymorphism; Prion protein; Strain; Transmission

Indexed keywords

GUANIDINE; ISOPROTEIN; METHIONINE; PRION PROTEIN; SWAINSONINE; VALINE;

ALPHA HELIX; AMINO ACID SEQUENCE; CARBOXY TERMINAL SEQUENCE; CLINICAL FEATURE; CODON; COPPER METABOLISM; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE PREDISPOSITION; ELECTROENCEPHALOGRAM; GENE CONVERSION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC HETEROGENEITY; GENOTYPE; GOLGI COMPLEX; HAPLOTYPE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; IN VITRO STUDY; INTERNALIZATION; KURU; LABORATORY DIAGNOSIS; MOLECULAR TYPING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPEN READING FRAME; PHENOTYPE; PHENOTYPIC VARIATION; PHYSICOCHEMICAL MODEL; PRION DISEASE; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; PROTEIN POLYMORPHISM; PYRAMIDAL SIGN; QUAKING INDUCED CONVERSION; REVIEW; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; SPORADIC CREUTZFELDT JAKOB DISEASE; TANDEM REPEAT; TRANSMISSIBLE MINK ENCEPHALOPATHY; VIRUS IDENTIFICATION; VIRUS STRAIN; VIRUS TRANSMISSION; WESTERN BLOTTING;

EID: 84860320398     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: None     Document Type: Review

References (193)

1. Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Ann Rev Neurosci 2008; 31: 439-477.
2. Aguzzi A, Heikenwalder M, Polymenidou M. Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 2007; 8: 552-561. (Pubitemid 46985384)
3. Atarashi R, Moore RA, Sim VL, Hughson AG, Dorward DW, Onwubiko HA, Priola SA, Caughey B. Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods 2007; 4: 645-650. (Pubitemid 47202476)
4. Atarashi R, Sano K, Satoh K, Nishida N. Real-time quaking-induced conversion: A highly sensitive assay for prion detection. Prion 2011; 5: 150-153.
5. Atarashi R, Satoh K, Sano K, Fuse T, Yamaguchi N, Ishibashi D, Matsubara T, Nakagaki T, Yamanaka H, Shirabe S, Yamada M, Mizusawa H, Kitamoto T, Klug G, McGlade A, Collins SJ, Nishida N. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 2011; 17: 175-178.
6. Atarashi R, Wilham JM, Christensen L, Hughson AG, Moore RA, Johnson LM, Onwubiko HA, Priola SA, Caughey B. Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods 2008; 5: 211-212.
7. Baron GS, Caughey B. Effect of glycosylphosphatidylinositol anchor-dependent and -independent prion protein association with model raft membranes on conversion to the protease-resistant isoform. J Biol Chem 2003; 278: 14883-14892. (Pubitemid 36799816)
8. Baron GS, Wehrly K, Dorward DW, Chesebro B, Caughey B. Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrPres (PrPSc) into contiguous membranes. EMBO J 2002; 21: 1031-1040. (Pubitemid 34206176)
9. Baron TG, Madec JY, Calavas D, Richard Y, Barillet F. Comparison of French natural scrapie isolates with bovine spongiform encephalopathy and experimental scrapie infected sheep. Neurosci Lett 2000; 284: 175-178 (Pubitemid 30204541)
10. Benestad SL, Arsac JN, Goldmann W, Nöremark M. Atypical/ Nor98 scrapie: properties of the agent, genetics, and epidemiology. Vet Res. 2008; 39: 19.
11. C retrograde transport toward the endoplasmic reticulum increases accumulation of PrPSc in prion-infected cells. J Biol Chem 2002; 27: 38972-38977.
12. Bessen RA, Kocisko DA, Raymond GJ, Nandan S, Lansbury PT, Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995; 375: 698-700.
13. Bessen RA, Marsh RF. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 1994; 68: 7859-7868. (Pubitemid 24362673)
14. Bieschke J, Weber P, Sarafoff N, Beekes M, Giese A, Kretzschmar H. Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci U S A 2004; 10: 12207-12211. (Pubitemid 39145421)
15. Bishop MT, Will RG, Manson JC. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 2010; 107: 12005-12010.
16. Borchelt DR, Taraboulos A, Prusiner SB. Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 1992; 267: 16188-16199.
17. Botto L, Masserini M, Cassetti A, Palestini P. Immunoseparation of prion protein-enriched domains from other detergent-resistant membrane fractions, isolated from neuronal cells. FEBS Lett 2004; 557: 143-147. (Pubitemid 38115885)
18. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, Fraser PE, Kruck T, von Bohlen A, Schulz-Schaeffer W, Giese A, Westaway D, Kretzschmar H. The cellular prion protein binds copper in vivo. Nature 1997; 390: 684-687 (Pubitemid 28016355)
19. Brown LR, Harris DA. Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi. J Neurochem 2003; 87: 353-363. (Pubitemid 37255243)
20. Brown P, Brandel JP, Preece M, Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006; 6: 389-393. (Pubitemid 44214958)
21. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35: 513-529. (Pubitemid 24153834)
22. Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 1991; 72: 595-603.
23. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C, Cousens S, Fraser H, Bostock CJ. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997; 389: 498-501. (Pubitemid 27435325)
24. Bruce ME. Strain typing studies on scrapie and BSE. In: Baker H, Ridley RM (eds.). Methods in Molecular Medicine: Prion Diseases. Humana Press Inc. 1996; p. 223.
25. Budka H, Head MW, Ironside JW. Sporadic Creutzfeldt-Jacob disease. In: Dickson DW and Weller RO (eds.). Neurodegeneration. Wiley-Blackwell, Chichester 2011; pp. 322-335
26. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73: 1339-1347. (Pubitemid 23201147)
27. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp H, Lipp P, DeArmond SJ, Prusiner SB, AguetM and Weissman C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356: 577-582.
28. Burkhard PR, Sanchez JC, Landis T, Hochstrasser DF. CSF detection of the 14-3-3 protein in unselected patients with dementia. Neurology. 2001; 56: 1528-1533. (Pubitemid 32532265)
29. Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, Langeveld JP, Parchi P, Safar JG, Zou WQ, Gambetti P. Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 2009; 132: 2643-2658.
30. Cali I, Castellani R, Yuan J, Al-Shekhlee A, Cohen ML, Xiao X, Moleres FJ, Parchi P, Zou WQ, Gambetti P. Classification of sporadic Creutzfeldt-Jakob disease revisited. Brain 2006; 129: 2266-2277. (Pubitemid 44522113)
31. Campana V, Sarnataro D, Zurzolo C. The highways and byways of prion protein trafficking. Trends Cell Biol 2005; 15: 102-111. (Pubitemid 40188220)
32. Capellari S, Parchi P, Russo CM, Sanford J, Sy MS, Gambetti P, Petersen RB Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain. Am J Pathol 2000; 157: 613-622. (Pubitemid 30626920)
33. Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P. Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 2011; 121: 21-37.
34. Castellani RJ, Colucci M, Xie Z, Zou W, Li C, Parchi P, Capellari S, Pastore M, Rahbar MH, Chen SG, Gambetti P. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. Neurology 2004; 63: 436-442. (Pubitemid 39031371)
35. Castilla J, Saá P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412: 3-21. (Pubitemid 44548570)
36. Castilla J, Saá P, Soto C. Detection of prions in blood. Nat Med 2005; 11: 982-985. (Pubitemid 41294444)
37. Caughey B, Raymond GJ, Bessen RA. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J Biol Chem 1998; 273: 32230-32235. (Pubitemid 29177169)
38. Caughey B, Raymond GJ, Kocisko DA, Lansbury PT, Jr. Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. J Virol 1997; 71: 4107-4110. (Pubitemid 27172429)
39. Caughey B, Raymond GJ. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 1991; 266: 18217-18223. (Pubitemid 21908068)
40. Caughey BW, Dong A, Bhat KS, Ernst D, Hayes SF, Caughey WS. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry 1991; 30: 7672-7680.
41. Chen SG, Teplow DB, Parchi P, Teller JK, Gambetti P, Autilio-Gambetti L. Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem 1995; 270: 19173-19180.
42. Chohan G, Pennington C, Mackenzie JM, Andrews M, Everington D, Will RG, Knight RS, Green AJ. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry 2010; 81: 1243-1248.
43. Colby DW, Prusiner SB. Prions. Cold Spring Harb Perspect Biol 2011; 3: a006833.
44. Colby DW, Zhang Q, Wang S, Groth D, Legname G, Riesner D, Prusiner SB. Prion detection by an amyloid seeding assay. Proc Natl Acad Sci U S A 2007; 104: 20914-20919.
45. Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science 2007; 318: 930-936. (Pubitemid 350098981)
46. Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996; 383: 685-690. (Pubitemid 26360638)
47. Collins S, Law MG, Fletcher, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case control study. Lancet 1999; 353: 693-697. (Pubitemid 29103801)
48. Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A, Pocchiari M, Almonti S, Cuadrado-Corrales N, de Pedro-Cuesta J, Budka H, Gelpi E, Glatzel M, Tolnay M, Hewer E, Zerr I, Heinemann U, Kretszchmar HA, Jansen GH, Olsen E, Mitrova E, Alpérovitch A, Brandel JP, Mackenzie J, Murray K, Will RG. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 2006; 129: 2278-2287. (Pubitemid 44522114)
49. Cronier S, Gros N, Tattum MH, Jackson GS, Clarke AR, Collinge J, Wadsworth JD. Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J. 2008; 416: 297-305.
50. DeArmond SJ, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB. Selective neuronal targeting in prion disease. Neuron 1997; 19: 1337-1348. (Pubitemid 28030552)
51. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A 2007; 104: 9741-9746. (Pubitemid 47175337)
52. Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 24: 329-332. (Pubitemid 29421804)
53. EigenM. Prionics or the kinetic basis of prion diseases. Biophys Chem 1996; 63: A1-18.
54. Farquhar CF, Somerville RA, Bruce ME. Straining the prion hypothesis. Nature 1998; 391: 345-346.
55. Fraser H, Dickinson AG. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 1973; 83: 29-40.
56. Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alshekhlee A, Castellani R, Cohen M, Barria MA, Gonzalez-Romero D, Belay ED, Schonberger LB, Marder K, Harris C, Burke JR, Montine T, Wisniewski T, Dickson DW, Soto C, Hulette CM, Mastrianni JA, Kong Q, Zou WQ. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. 2008; 63: 697-708. (Pubitemid 351945529)
57. Gambetti P, Zou WQ, Torres JM, Soto C, Notari S, Espinosa JC, Xiao X. Variably protease-sensitive prionopathy: transmissibility and PMCA studies. Prion 2011; 5: 14.
58. Gao JM, Zhou XB, Xiao XL, Zhang J, Chen L, Gao C, Zhang BY, Dong XP. Influence of guanidine on proteinase K resistance in vitro and infectivity of scrapie prion protein PrPSc. Acta Virol 2006; 50: 25-32. (Pubitemid 47434335)
59. Ghetti B, Tagliavini F, Kovacs GG, Piccardo P. Gertsmann-Sträussler- Scheinker disease. In: Dickson DW and Weller RO (eds.). Neurodegeneration. Wiley-Blackwell, Chichester 2011; pp. 364-377.
60. Glatzel M, Rogivue C, Ghani A, Streffer JR, Amsler L, Aguzzi A. Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 2002; 360: 139-141. (Pubitemid 34786205)
61. Gmitterová K, Heinemann U, Bodemer M, Krasnianski A, Meissner B, Kretzschmar HA, Zerr I. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes. Neurobiol Aging 2009; 30: 1842-1850.
62. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, Baskakov IV. Highly efficient protein misfolding cyclic amplification. PLoS Pathog 2011; 7: e1001277.
63. Haik S, Galanaud D, Linguraru MG, Peoc'h K, Privat N, Faucheux BA, Ayache N, Hauw JJ, Dormont D, Brandel JP. In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. Arch Neurol 2008; 65: 545-549. (Pubitemid 351549967)
64. Hamaguchi T, Kitamoto T, Sato T, Mizusawa H, Nakamura Y, Noguchi M, Furukawa Y, Ishida C, Kuji I, Mitani K, Murayama S, Kohriyama T, Katayama S, Yamashita M, Yamamoto T, Udaka F, Kawakami A, Ihara Y, Nishinaka T, Kuroda S, Suzuki N, Shiga Y, Arai H, Maruyama M, YamadaM. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology 2005; 64: 643-648. (Pubitemid 40261892)
65. Harris DA. Trafficking, turnover and membrane topology of PrP. Br Med Bull 2003; 66: 71-85. (Pubitemid 37173493)
66. Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, Williams MC, McCardle L, MacKenzie J, Knight R, Will RG, Ironside JW). Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 2004; 55: 851-859. (Pubitemid 38702581)
67. Head MW, Ironside JW. Sporadic Creutzfeldt-Jakob disease: discrete subtypes or a spectrum of disease? Brain 2009; 132: 2627-2629.
68. Head MW, Knight R, Zeidler M, Yull H, Barlow A, Ironside JW. A case of protease sensitive prionopathy in a patient in the UK. Neuropathol Appl Neurobiol 2009; 35: 628-632.
69. Head MW, Lowrie S, Chohan G, Knight R, Scoones DJ, Ironside JW. Variably protease-sensitive prionopathy in a PRNP codon 129 heterozygous UK patient with co-existing tau, α synuclein and Aβ pathology. Acta Neuropathol 2010; 120: 821-823.
70. Hecker R, Taraboulos A, Scott M, Pan KM, Yang SL, Torchia M, Jendroska K, DeArmond SJ, Prusiner SB. Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev 1992; 6: 1213-1228.
71. Herms J, Tings T, Gall S, Madlung A, Giese A, Siebert H, Schurmann P, Windl O, Brose N, Kretzschmar H. Evidence of presynaptic location and function of the prion protein. J Neurosci 1999; 19: 8866-8875. (Pubitemid 30226708)
72. Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P. The same prion strain causes vCJD and BSE. Nature 1997; 389: 448-450, 526.
73. Hill AF, Joiner S, Beck JA, Campbell TA, Dickinson A, Poulter M, Wadsworth JD, Collinge J. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 2006; 129: 676-685. (Pubitemid 43278229)
74. Horiuchi M, Caughey B. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state. EMBO J 1999; 18: 3193-3203. (Pubitemid 29276566)
75. Hornshaw MP, McDermott JR, Candy JM, Lakey JH. Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun 1995; 214: 993-999.
76. Hsich G, Kenney K, Gibbs CJ, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996; 335: 924-930. (Pubitemid 26314445)
77. Ironside JW, Head MW, Will RG. Variant Creutzfeldt-Jacob disease. In: Dickson DW and Weller RO (eds.). Neurodegeneration. Wiley-Blackwell, Chichester 2011; pp. 354-363.
78. Ironside JW, Knight RSG, Head MW. Iatrogenic Creutzfeldt-Jacob disease. In: Dickson DW and Weller RO (eds.). Neurodegeneration. Wiley-Blackwell, Chichester 2011; pp. 381-388.
79. Jansen C, Head MW, van Gool WA, Baas F, Yull H, Ironside JW, Rozemuller AJ. The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype. J Neurol Neurosurg Psychiatry 2010; 81: 1052-1055.
80. Jansen C, Parchi P, Capellari S, Ibrahim-Verbaas CA, Schuur M, Strammiello R, Corrado P, Bishop MT, van Gool VA, Verbeek MM, Baas F, van Saane V, Spliet WGM, Jansen GH, van Duijn CM, Rozemuller AJM. Human prion diseases in The Netherlands (1998-2009): Clinical, genetic and molecular aspects. PloS One 2012 (in press).
81. Jansen C, Parchi P, Capellari S, Strammiello R, Dopper EG, van Swieten JC, Kamphorst W, Rozemuller AJ. A second case of Gerstmann-Sträussler- Scheinker disease linked to the G131V mutation in the prion protein gene in a Dutch patient. J Neuropathol Exp Neurol 2011; 70: 698-702.
82. Jones M, Peden AH, Prowse CV, Gröner A, Manson JC, Turner ML, Ironside JW, MacGregor IR, Head MW. in vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol 2007; 213: 21-26. (Pubitemid 47354562)
83. Jones M, Peden AH, Wight D, Prowse C, Macgregor I, Manson J, Turner M, Ironside JW, Head MW. Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport 2008; 19: 1783-1786.
84. Jones M, Wight D, Barron R, Jeffrey M, Manson J, Prowse C, Ironside JW, Head MW. Molecular model of prion transmission to humans. Emerg Infect Dis 2009; 15: 2013-2016.
85. Kaneko K, Vey M, Scott M, Pilkuhn S, Cohen FE, Prusiner SB. COOH-terminal sequence of the cellular prion protein directs subcellular trafficking and controls conversion into the scrapie isoform. Proc Natl Acad Sci U S A 1997; 94: 2333-2338. (Pubitemid 27136875)
86. Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Safar JG. Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 2011; 7: e1002242.
87. Kitamoto T, Mohri S, Ironside JW, Miyoshi I, Tanaka T, Kitamoto N, Itohara S, Kasai N, Katsuki M, Higuchi J, Muramoto T, Shin RW. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions. Biochem Biophys Res Commun 2002; 294: 280-286. (Pubitemid 34694090)
88. Kobayashi A, Arima K, Ogawa M, Murata M, Fukuda T, Kitamoto T. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients. Acta Neuropathol 2008; 116: 561-566.
89. Kobayashi A, Mizukoshi K, Iwasaki Y, Miyata H, Yoshida Y, Kitamoto T. Co-occurrence of types 1 and 2 PrPres in sporadic Creutzfeldt-Jakob disease MM1. Am J Pathol 2011; 178: 1309-1315.
90. Kobayashi A, Sakuma N, Matsuura Y, Mohri S, Aguzzi A, Kitamoto T. Experimental verification of a traceback phenomenon in prion infection. J Virol 2010; 84: 3230-3238.
91. Kocisko DA, Come, JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B. Cell-free formation of protease-resistant prion protein. Nature 1994; 370: 471-474. (Pubitemid 24263553)
92. Kocisko DA, Lansbury PT Jr, Caughey B. Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry 1996; 35: 13434-13442. (Pubitemid 26349439)
93. Korth C, Kaneko K, Groth D, Heye N, Telling G, Mastrianni J, Parchi P, Gambetti P, Will R, Ironside J, Heinrich C, Tremblay P, DeArmond SJ, Prusiner SB. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc Natl Acad Sci U S A 2003; 100: 4784-4789. (Pubitemid 36457806)
94. Kuczius T, Koch R, Keyvani K, Karch H, Grassi J, Groschup MH. Regional and phenotype heterogeneity of cellular prion proteins in the human brain. Eur J Neurosci 2007; 25: 2649-2655. (Pubitemid 46888834)
95. Lasmezas CI, Fournier JG, Nouvel V, Boe H, Marce D, Lamoury F, Kopp N, Hauw JJ, Ironside J, Bruce M, Dormont D, Deslys JP Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: implications for human health. Proc Natl Acad Sci U S A 2001; 98: 4142-4147. (Pubitemid 32249912)
96. Lee KS, Magalhǎ;es AC, Zanata SM, Brentani RR, Martins VR, Prado MA. Internalization of mammalian fluorescent cellular prion protein and N-terminal deletion mutants in living cells. J Neurochem 2001; 79: 79-87. (Pubitemid 32946645)
97. Legname G, Nguyen HO, Baskakov IV, Cohen FE, Dearmond SJ, Prusiner SB. Strain-specified characteristics of mouse synthetic prions. Proc Natl Acad Sci U S A 2005; 102: 2168-2173. (Pubitemid 40262030)
98. Legname G, Nguyen HO, Peretz D, Cohen FE, DeArmond SJ, Prusiner SB. Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes. Proc Natl Acad Sci U S A 2006; 103: 19105-19110. (Pubitemid 350002835)
99. Levavasseur E, Laffont-Proust I, Morain E, Faucheux BA, Privat N, Peoc'h K, Sazdovitch V, Brandel JP, Hauw JJ, Haik S. Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease-implications for the dissemination and the diagnosis of human prion strains. PLoS One 2008; 3: e2786.
100. Lewis V, Hill AF, Klug GM, Boyd A, Masters CL, Collins SJ. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles. Neurology 2005; 65: 113-118. (Pubitemid 40967785)
101. Li J, Browning S, Mahal SP, Oelschlegel AM, Weissmann C. Darwinian evolution of prions in cell culture. Science. 2010; 327: 869-872.
102. Li J, Mahal SP, Demczyk CA, Weissmann C. Mutability of prions. EMBO Rep 2011; 12: 1243-1250.
103. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88: 673-728. (Pubitemid 351520090)
104. Liu C, Zhang Y. Nucleic acid-mediated protein aggregation and assembly. Adv Protein Chem Struct Biol 2011; 84: 1-40.
105. Lodi R, Parchi P, Tonon C, Manners D, Capellari S, Strammiello R, Rinaldi R, Testa C, Malucelli E, Mostacci B, Rizzo G, Pierangeli G, Cortelli P, Montagna P, Barbiroli B. Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study. Brain 2009; 132: 2669-2679.
106. Mallucci G, Dickinson A, Linehan J, Klöhn PC, Brandner S, Collinge J. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 2003; 302: 871-874. (Pubitemid 37339628)
107. Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002; 21: 202-210. (Pubitemid 34137282)
108. Manners DN, Parchi P, Tonon C, Capellari S, Strammiello R, Testa C, Tani G, Malucelli E, Spagnolo C, Cortelli P, Montagna P, Lodi R, Barbiroli B. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease. Neurology 2009; 72: 1425-1431.
109. Mastrianni JA, Nixon R, Layzer R, Telling GC, Han D, DeArmond SJ, Prusiner SB. Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 1999; 340: 1630-1638. (Pubitemid 29249432)
110. McGuire LI, Peden AH, Appleford N, Mallinson G, Orrů C, Wilham J, Raymond G, Andrews M, Head MW, Caughey B, Will R, Knight R, Green A. Prion seeding activity in cerebrospinal fluid from sporadic Creutzfeldt-Jacob disease patients using real-time QuIC analysis: a potential new diafgnostic test? Prion 2011; 5: 18.
111. McLean CA. Kuru. In: Dickson DW and Weller RO (ed). Neurodegeneration. Wiley-Blackwell, Chichester 2011, pp. 354-363.
112. Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S, Collins SJ, Smith P, Cras P, Jansen GH, Brandel JP, Coulthart MB, Roberts H, Van Everbroeck B, Galanaud D, Mellina V, Will RG, Zerr I. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 2009; 72: 1994-2001.
113. Meissner B, Westner IM, Kallenberg K, Krasnianski A, Bartl M, Varges D, Bösenberg C, Kretzschmar HA, Knauth M, Schulz-Schaeffer WJ, Zerr I. Sporadic Creutzfeldt-Jakob disease: clinical and diagnostic characteristics of the rare VV1 type. Neurology 2005; 65: 1544-1550. (Pubitemid 41689466)
114. Moda F, Suardi S, Di Fede G, Indaco A, Limido L, Vimercati C, Ruggerone M, Campagnani I, Langeveld J, Terruzzi A, Brambilla A, Zerbi P, Fociani P, Bishop MT, Will RG, Manson JC, Giaccone G, Tagliavini F. MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain. Brain Pathol 2012 Jan 30 [Epub ahead of print]
115. Monari L, Chen SG, Brown P, Parchi P, Petersen RB, Mikol J, Gray F, Cortelli P, Montagna P, Ghetti B, Goldfarb LG, Gajdusek DC, Lugaresi E, Gambetti P, Autilio-Gambetti L. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A 1994; 91: 2839-2842. (Pubitemid 24139444)
116. Montagna P, Gambetti P, Cortelli P, Lugaresi E. Familial and sporadic fatal insomnia. Lancet Neurol 2003; 2: 167-176. (Pubitemid 37443320)
117. Naslavsky N, Stein R, Yanai A, Friedlander G, Taraboulos A. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem 1997; 272: 6324-6331. (Pubitemid 27118107)
118. Nazor KE, Kuhn F, Seward T, Green M, Zwald D, Pürro M, Schmid J, Biffiger K, Power AM, Oesch B, Raeber AJ, Telling GC. Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice. EMBO J 2005; 24: 2472-2480. (Pubitemid 41032597)
119. Nonno R, Di Bari MA, Cardone F, Vaccari G, Fazzi P, Dell'Omo G, Cartoni C, Ingrosso L, Boyle A, Galeno R, Sbriccoli M, Lipp HP, Bruce M, Pocchiari M, Agrimi U. Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog 2006; 2: e12.
120. Notari S, Capellari S, Giese A, Westner I, Baruzzi A, Ghetti B, Gambetti P, Kretzschmar HA, Parchi P Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J Biol Chem 2004; 279: 16797-16804. (Pubitemid 38509382)
121. Notari S, Capellari S, Langeveld J, Giese A, Strammiello R, Gambetti P, Kretzschmar HA, Parchi P. A refined method for molecular typing reveals that co-occurrence of PrPSc types in Creutzfeldt-Jakob disease is not the rule. Lab Invest 2007; 87: 1103-1112. (Pubitemid 47609028)
122. Notari S, Strammiello R, Capellari S, Giese A, Cescatti M, Grassi J, Ghetti B, Langeveld JP, Zou WQ, Gambetti P, Kretzschmar HA, Parchi P. Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J Biol Chem 2008; 283: 30557-30565.
123. Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S. Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2002; 58: 192-197. (Pubitemid 34084207)
124. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991; 352: 340-342. (Pubitemid 21912354)
125. Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993; 90: 10962-10966.
126. Pan T, Colucci M, Wong BS, Li R, Liu T, Petersen RB, Chen S, Gambetti P, Sy MS. Novel differences between two human prion strains revealed by two-dimensional gel electrophoresis. J Biol Chem 2001; 276: 37284-37288.
127. Parchi P, Capellari S, Chen SG, Petersen RB, Gambetti P, Kopp N, Brown P, Kitamoto T, Tateishi J, Giese A, Kretzschmar H. Typing prion isoforms. Nature 1997; 386: 232-234.
128. Parchi P, Capellari S, Chin S, Schwarz HB, Schecter NP, Butts JD, Hudkins P, Burns DK, Powers JM, Gambetti P. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999; 52: 1757-1763. (Pubitemid 29260886)
129. Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ, Petersen RB, Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 1996; 39: 767-778. (Pubitemid 26183813)
130. Parchi P, Cescatti M, Notari S, Schulz-Schaeffer WJ, Capellari S, Giese A, Zou WQ, Kretzschmar H, Ghetti B, Brown P. Agent strain variation in human prion disease: insights from amolecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 2010; 133: 3030-3042.
131. Parchi P, Chen SG, Brown P, Zou W, Capellari S, Budka H, Hainfellner J, Reyes PF, Golden GT, Hauw JJ, Gajdusek DC, Gambetti P Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci U S A 1998; 95: 8322-8327.
132. Parchi P, Gambetti P, Capellari S. Genetic Creutfeldt-Jacob disease. In: Dickson DW and Weller RO (eds.). Neurodegeneration. Wiley-Blackwell, Chichester 2011; pp. 336-345.
133. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233 (Pubitemid 29382879)
134. Sc typing in Creutzfeldt-Jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol 2009; 19: 384-391.
135. Sc types: an updated classification. Acta Neuropathol 2009; 118: 659-671.
136. Parchi P, Zou W, Wang W, Brown P, Capellari S, Ghetti B, Kopp N, Schulz-Schaeffer WJ, Kretzschmar HA, Head MW, Ironside JW, Gambetti P, Chen SG. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci U S A 2000; 97: 10168-10172.
137. Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C, Requena
138. Pattison IH, Millson GC. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J Comp Pathol 1961; 71: 101-109.
139. Pauly PC, Harris DA. Copper stimulates endocytosis of the prion protein. J Biol Chem 1998; 273: 33107-33110. (Pubitemid 29005676)
140. Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, Orrú CD, Caughey B, Ironside JW, Knight RS, Will RG, Green AJ, Head MW. Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quakinginduced conversion. J Gen Virol 2012; 93: 438-449.
141. Perera WS, Hooper NM. Ablation of the metal ion-induced endocytosis of the prion protein by disease-associated mutation of the octarepeat region. Curr Biol 2001; 11: 519-523.
142. Peretz D, Scott MR, Groth D, Williamson RA, Burton DR, Cohen FE, Prusiner SB. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci 2001; 10: 854-863. (Pubitemid 32240511)
143. Peters PJ, Mironov A Jr, Peretz D, van Donselaar E, Leclerc E, Erpel S, DeArmond SJ, Burton DR, Williamson RA, Vey M, Prusiner SB. Trafficking of prion proteins through a caveolae-mediated endosomal pathway. J Cell Biol 2003; 162: 703-717. (Pubitemid 37022947)
144. Piccardo P, Dlouhy SR, Lievens PM, Young K, Bird TD, Nochlin D, Dickson DW, Vinters HV, Zimmerman TR, Mackenzie IR, Kish SJ, Ang LC, De Carli C, Pocchiari M, Brown P, Gibbs CJ, Jr., Gajdusek DC, Bugiani O, Ironside J, Tagliavini F, Ghetti B. Phenotypic variability of Gerstmann-Sträussler- Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998; 57: 979-988. (Pubitemid 28478008)
145. Pinheiro TJ. The role of rafts in the fibrillization and aggregation of prions. Chem Phys Lipids 2006; 141: 66-71. (Pubitemid 43728805)
146. Pirisinu L, Di Bari M, Marcon S, Vaccari G, D'Agostino C, Fazzi P, Esposito E, Galeno R, Langeveld J, Agrimi U, Nonno R. A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrP. PLoS One 2010; 5: e12723.
147. Polymenidou M, Prokop S, Jung HH, Hewer E, Peretz D, Moos R, Tolnay M, Aguzzi A. Atypical prion protein conformation in familial prion disease with PRNP P105T mutation. Brain Pathol 2011; 21: 209-214.
148. Polymenidou M, Stoeck K, Glatzel M, Vey M, Bellon A, Aguzzi A Coexistence of multiple PrPSc types in individuals with Creutzfeldt-Jakob disease. Lancet Neurol 2005; 4: 805-814. (Pubitemid 41619435)
149. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 21: 136-144. (Pubitemid 12089840)
150. Prusiner SB. Prions. Proc Natl Acad Sci USA1998; 95: 13363-13383. (Pubitemid 28525623)
151. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrPSc in the same brain. Neurology 1999; 53: 2173-2176.
152. Rodríguez-Martínez AB, Garrido JM, Zarranz JJ, Arteagoitia JM, de Pancorbo MM, Atarés B, Bilbao MJ, Ferrer I, Juste RA. A novel form of human disease with a protease-sensitive prion protein and heterozygosity methionine/valine at codon 129: Case report. BMC Neurol 2010; 10: 99.
153. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411: 810-813. (Pubitemid 32588105)
154. Safar J, Roller PP, Gajdusek DC, Gibbs CJ Jr. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein. J Biol Chem 1993; 268: 20276-20284. (Pubitemid 23278933)
155. Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M, Cohen FE, Prusiner SB. Eight prion strains have PrPScmolecules with different conformations. Nat Med 1998; 4: 1157-1165. (Pubitemid 28468829)
156. Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, Serban A, Vey M, Baron H, Giles K, Miller BL, Dearmond SJ, Prusiner SB. Diagnosis of human prion disease. Proc Natl Acad Sci U S A 2005; 102: 3501-3506. (Pubitemid 40328074)
157. Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, Riesner D. Search for a prion-specific nucleic acid. J Virol 2005; 79: 10796-10806. (Pubitemid 41098618)
158. Sakaguchi S, Katamine S, Nishida N, Moriuchi R, Shigematsu K, Sugimoto T, Nakatani A, Kataoka Y, Houtani T, Shirabe S, Okada H, Hasegawa S, Miyamoto T, Noda T. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 1996; 380: 528-531. (Pubitemid 26110641)
159. Salvatore M, Genuardi M, Petraroli R, Masullo C, D'Alessandro M, PocchiariM. Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genet 1994; 94: 375-379. (Pubitemid 24297722)
160. Samaia HB, Brentani RR. Can loss-of-function prion-related diseases exist? Mol Psychiatry 1998; 3: 196-197. (Pubitemid 28266324)
161. Sanchez-Juan P, Green A, Ladogana A, Cuadrado-Corrales N, Saanchez-Valle R, Mitrovaa E, Stoeck K, Sklaviadis T, Kulczycki J, Hess K, Bodemer M, Slivarichova D, Saiz A, Calero M, Ingrosso L, Knight R, Janssens AC, van Duijn CM, Zerr I. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology 2006; 67: 637-643. (Pubitemid 44273611)
162. Sarnataro D, Campana V, Paladino S, Stornaiuolo M, Nitsch L, Zurzolo C. PrPC association with lipid rafts in the early secretory pathway stabilizes its cellular conformation. Mol Biol Cell 2004; 15: 4031-4042. (Pubitemid 39122009)
163. Sarnataro D, Paladino S, Campana V, Grassi J, Nitsch L, Zurzolo C. PrPC is sorted to the basolateral membrane of epithelial cells independently of its association with rafts. Traffic 2002; 3: 810-821. (Pubitemid 35277007)
164. Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K. Total Tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease. Dement Geriatr Cogn Disord 2007; 24: 207-212. (Pubitemid 47312671)
165. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, Eguhchi K, Shirabe S, Sata T. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 2010; 90: 1637-1644.
166. Sc profiling in sporadic Creutzfeldt-Jakob disease. PLoS 2006; Med 3: e14.
167. Shorter J. Emergence and natural selection of drug-resistant prions. Mol Biosyst 2010; 6: 1115-1130.
168. Simoneau S, Ruchoux MM., Vignier N, Lebon P, Freire S, Comoy E, Deslys JP, Fournier JG. Small critical RNAs in the scrapie agent. Nature Precedings 2009; Available at http://hdl.handle.net/10101/ npre.2009.3344.1.
169. Somerville RA, Chong A, Mulqueen OU, Birkett CR, Wood SC, Hope J. Biochemical typing of scrapie strains. Nature 1997; 386: 564.
170. Somerville RA, Hamilton S, Fernie K. Transmissible spongiform encephalopathy strain, PrP genotype and brain region all affect the degree of glycosylation of PrPSc. J Gen Virol 2005; 86: 241-246. (Pubitemid 40081172)
171. Soto C, Saborio GP, Anderes L. Cyclic amplification of protein misfolding: application to prion-related disorders and beyond. Trends Neurosci 2002; 25: 390-394. (Pubitemid 34804458)
172. Stack MJ, Chaplin MJ, Clark J. Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathol 2002; 104: 279-286. (Pubitemid 36075389)
173. Sunyach C, Jen A, Deng J, Fitzgerald KT, Frobert Y, Grassi J, McCaffrey MW, Morris R. The mechanism of internalization of glycosylphosphatidylinositol- anchored prion protein. EMBO J 2003; 22: 3591-3601. (Pubitemid 36898336)
174. Tagliavini F, Prelli F, Ghiso J, Bugiani O, Serban D, Prusiner SB, Farlow MR, Ghetti B, Frangione B. Amyloid protein of Gerstmann-Straussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J 1991; 10: 513-519. (Pubitemid 21905503)
175. Taraboulos A, Raeber AJ, Borchelt DR, Serban D, Prusiner SB. Synthesis and trafficking of prion proteins in cultured cells. Mol Biol Cell 1992; 3: 851-863. (Pubitemid 23079759)
176. Taraboulos A, Scott M, Semenov A, Avrahami D, Laszlo L, Prusiner SB. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol 1995; 129: 121-132.
177. Telling GC, Parchi P, DeArmond SJ, Cortelli P, Montagna P, Gabizon R, Mastrianni J, Lugaresi E, Gambetti P, Prusiner SB. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996; 274: 2079-2082. (Pubitemid 27020700)
178. Thackray AM, Hopkins L, Klein MA, Bujdoso R. Mouse-adapted ovine scrapie prion strains are characterized by different conformers of PrPSc. J Virol 2007; 81: 12119-12127. (Pubitemid 350085827)
179. Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41: 12868-12875. (Pubitemid 35192516)
180. res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog 2008; 4: e1000029.
181. Vey M, Pilkuhn S, Wille H, Nixon R, DeArmond SJ, Smart EJ, Anderson RG, Taraboulos A, Prusiner SB. Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A 1996; 93: 14945-14949. (Pubitemid 26419075)
182. Weissmann C. Molecular genetics of transmissible spongiform encephalopathies. J Biol Chem 1999; 274: 3-6. (Pubitemid 29035021)
183. Wilham JM, Orrú CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B. Rapid endpoint quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 2010; 6: e1001217.
184. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996; 347: 921-925. (Pubitemid 26102546)
185. Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KC, Palmer MS, Collinge J. Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 1996; 98: 259-264. (Pubitemid 26258371)
186. Yokoyama T, Takeuchi A, Yamamoto M, Kitamoto T, Ironside JW, Morita M. Heparin enhances the cell-protein misfolding cyclic amplification efficiency of variant Creutzfeldt-Jakob disease. Neurosci Lett 2011; 498: 119-123.
187. Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Head MW. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol 2006; 168: 151-157. (Pubitemid 43062568)
188. Zanusso G, Fiorini M, Ferrari S, Gajofatto A, Cagnin A, Galassi A, Richelli S, Monaco S. Cerebrospinal fluid markers in sporadic creutzfeldt-jakob disease. Int J Mol Sci 2011; 12: 6281-6292.
189. Zanusso G, Polo A, Farinazzo A, Nonno R, Cardone F, Di Bari M, Ferrari S, Principe S, Gelati M, Fasoli E, Fiorini M, Prelli F, Frangione B, Tridente G, Bentivoglio M, Giorgi A, Schininŕ ME, Maras B, Agrimi U, Rizzuto N, Pocchiari M, Monaco S. Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease. Arch Neurol 2007; 64: 595-599. (Pubitemid 46588352)
190. Zeidler M, Sellar RJ, Collie DA, Knight R, Stewart G, Macleod MA, Ironside JW, Cousens S, Colchester AC, Hadley DM, Will RG. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000; 355: 1412-1418. (Pubitemid 30215964)
191. Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009; 132: 2659-2668.
192. Zou WQ, Capellari S, Parchi P, Sy MS, Gambetti P, Chen SG. Identification of novel proteinase K-resistant C-terminal fragments of PrP in Creutzfeldt-Jakob disease. J Biol Chem 2003; 278: 40429-40436. (Pubitemid 37280852)
193. Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S, Crain B, Schmidt RE, Geschwind M, Dearmond SJ, Cairns NJ, Dickson D, Honig L, Torres JM, Mastrianni J, Capellari S, Giaccone G, Belay ED, Schonberger LB, Cohen M, Perry G, Kong Q, Parchi P, Tagliavini F, Gambetti P. Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein. Ann Neurol 2010; 68: 162-172.